ERNAW

Conviction 0HealthcareScan · Mon, Aug 10, 2026

ERNAW$0.0690+81.58%

ResistanceSupportVol 14

Vol MA14 13.67K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Ernexa Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.ernexatx.com ↗

Price0.0690

Change+81.58%

Gap+81.58%

Rel volume0.00×

Avg volume13.52K

Avg $ vol780.54

SMA 200.0534

SMA 500.0640

SMA 200—

Price vs 50+7.87%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 0.1164

RSI (14)53

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D60 / 51

ADX (14)19

+DI / −DI40 / 24

RSI divergence—

MACD divergence—

ATR %+49.82%

ADR %36.77%

52w high0.1799

52w low0.0000

From 52w high-61.65%

Above 52w low—

New 52w highNo

SqueezeOn · 2d

Bollinger width169.60%

%B0.67

Donchian pos44.52%

Donchian high0.1550

Donchian low0.0000

AVWAP (52w high)0.1321

vs AVWAP high-47.75%

AVWAP (52w low)0.1133

vs AVWAP low-39.12%

OBV trendDown

Chaikin MF (20)-0.62

Today vs 20d0.00×

Avg vol (14d)13.67K

Avg vol (20d)13.52K

Avg $ vol (20d)780.54

Market cap112.64K

RS 3m (vs SPY)-63.48%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank56.5

1 week+38.00%

1 month—

3 months-8.00%

6 months-31.00%

1 year—

YTD-31.00%

P/E-0.01

P/B0.04

P/S0.02

P/FCF-0.02

EPS-2.24

Div yield—

ROE-440.13%

ROA-223.02%

Debt/Eq0.64

Current2.01

EV/EBITDA0.23

Gross margin8.38%

Net margin-242.83%

Rev growth-70.72%

EPS growth68.38%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-2.17M

Revenue1.48M

Net income-4.01M

Gross profit547K

Free cash flow-7.05M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out13.6M

Employees5

ListedFri, Feb 6, 2026

Free float1.63M

Float %100.0%

Short interest803

Days to cover0.1d

Short volume—

Squeeze score1 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank56.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.1420

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ERNAW

All disclosures →

No recent disclosed trades by Congress in ERNAW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ERNAW

No recent insider (Form 4) filings in ERNAW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ERNAW

EDGAR →

No recent SEC filings on file for ERNAW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.